Diluted and Undiluted Enteral Nutrition
Launched by MEDICAL UNIVERSITY OF LUBLIN · Jul 17, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different types of feeding impact patients after major abdominal surgeries. Specifically, it will compare two methods of enteral nutrition (EN), which is feeding patients directly through their digestive system. One group of patients will receive diluted EN with additional fluids, while the other group will get undiluted EN. The main goal of the study is to see how well patients tolerate these feeding methods, especially in the critical care setting.
To participate in this trial, patients must be scheduled for major abdominal surgery that will require a stay in the Intensive Care Unit (ICU) and must have a functioning gastrointestinal tract for feeding. Unfortunately, those who have had emergency surgeries, cannot provide informed consent, or have certain health conditions that make enteral feeding unsafe won't be eligible. This study is not yet recruiting participants, but it aims to help improve the quality of life for patients who need specialized nutritional support after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Scheduled for major abdominal surgery requiring ICU admission
- • Having access to the GI tract (gastric or jejunal)
- • Planned to be fed enterally
- Exclusion Criteria:
- • Patients unable to give informed consent
- • After emergency surgeries
- • Without access to the GI tract
- • Individuals with contraindications to EN, such as short bowel syndrome, uncompensated shock, acidosis (pH \< 7.1; lactate \> 5 mmol/l), bleeding from the upper GI tract, obstruction, intestinal ischemia, abdominal compartment syndrome
- • Patients with symptomatic gastro-esophageal reflux
- • Expected ICU stay \< 3 days
- • Pregnancy and lactation
About Medical University Of Lublin
The Medical University of Lublin is a distinguished academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters a vibrant environment for medical and scientific inquiry, aiming to improve patient outcomes and contribute to the broader medical community. Its commitment to ethical research practices and patient safety ensures that all clinical trials conducted under its auspices adhere to the highest standards of scientific rigor and regulatory compliance. The Medical University of Lublin is positioned at the forefront of medical education and research in Poland, making significant contributions to the fields of medicine, pharmacy, and health sciences.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Opole, , Poland
Lublin, , Poland
Gorzów Wielkopolski, , Poland
Kraków, , Poland
Lublin, , Poland
Patients applied
Trial Officials
Michal Borys, MD, PhD
Principal Investigator
Medical University of Lublin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported